ELORES: A NOVEL TREATMENT APPROACH IN ELECTRIC BURN PATIENT WITH BACTEREMIA AND VENTILATOR-ASSOCIATED PNEUMONIA: A CASE STUDY
Abstract
ABSTRACT
Rising challenge in treating nearly a million burn patients in India, with high mortality and morbidity attributed to nosocomial infections, is a
serious concern. With cascades of reactions taking place in serious burn patients, there is a massive release of humoral factors, such as cytokines,
prostaglandins, vasoactive prostanoids, and leukotrienes, along with multiple defects of cellular and humoral components of defense system. This
immunocompromised state favors increased chances of nosocomial infections such as pneumonia and blood stream infections. The present case
discusses a novel treatment approach with Elores (ceftriaxone, sulbactam, and adjuvant disodium edetate) in effectively treating burn patient with
bacteremia and ventilator-associated pneumonia.
Keywords: Bacteremia, Elores, Electric burns, Ventilator-associated pneumonia.
Downloads
References
REFERENCES
Huzar TF, Cross JM. Ventilator-associated pneumonia in burn patients:
A cause or consequence of critical illness? Expert Rev Respir Med
;5(5):663-73.
Fouzia B, Damle AS, Maher G. Changing patterns of burn infections.
IOSR J Dent Med Sci 2013;5(4):11-4.
Mayhall CG. The epidemiology of burn wound infections: Then and
now. Clin Infect Dis 2003;37(4):543-50.
Brusselaers N, Logie D, Vogelaers D, Monstrey S, Blot S. Burns,
inhalation injury and ventilator-associated pneumonia: Value of routine
surveillance cultures. Burns 2012;38(3):364-70.
Jeschke MG, Kamolz LP, Sjöberg F, Wolf SE. Handbook of Burns:
Acute Burn Care. Vol. 1. New York: Springer Wien; 2012. p. 227.
de La Cal MA, Cerdá E, GarcÃa-Hierro P, Lorente L, SánchezConcheiro
M,
DÃaz C,
et
al.
Pneumonia
in
patients
with
severe
burns:
A
classification according
to
the
concept
of
the carrier
state.
Chest
;119(4):1160-5.
Anvarinejad M, Japoni A, Rafaatpour N, Mardaneh J, Abbasi P, Amin
Shahidi M, et al. Burn patients infected with metallo-beta-lactamaseproducing
Pseudomonas
aeruginosa:
Multidrug-resistant strains.
Arch
Trauma
Res 2014;3(2):e18182.
Biswal I, Arora BS, Kasana D, Neetushree. Incidence of multidrug
resistant Pseudomonas aeruginosa isolated from burn patients and
environment of teaching institution. J Clin Diagn Res 2014;8(5):DC26-9.
Turner KH, Everett J, Trivedi U, Rumbaugh KP, Whiteley M.
Requirements for Pseudomonas aeruginosa acute burn and chronic
surgical wound infection. PLoS Genet 2014;10(7):e1004518.
D’Avignon LC, Murray CK. Fever in the burn patient. Infect Dis
Antimicrob Agents. Available from: http://www.antimicrobe.org/e44.
asp.
Azimi L, Motevallian A, Ebrahimzadeh Namvar A, Asghari B, Lari AR.
Nosocomial infections in burned patients in Motahari hospital, Tehran,
Iran. Dermatol Res Pract 2011;2011:436952.
Lee HG, Jang J, Choi JE, Chung DC, Han JW, Woo H, et al. Blood
stream infections in patients in the burn intensive care unit. Infect
Chemother 2013;45(2):194-201.
Luo J, Guo GH. Interpretation for practice guidelines for prevention,
diagnosis, and treatment of ventilator-associated pneumonia in burn
patients by American burn association. Burns Trauma 2015;3:11.
Avni T, Levcovich A, Ad-El DD, Leibovici L, Paul M. Prophylactic
antibiotics for burns patients: Systematic review and meta-analysis.
BMJ 2010;340:c241.
Chaudhary M, Payasi A. Ethylenediaminetetraacetic acid: A nonantibiotic
adjuvant
enhancing Pseudomonas
aeruginosa
susceptibility.
Afr
J Microbiol Res 2012;6(39):6799-804.
Chaudhary M, Payasi A. Incidence, prevalence and control of multidrug
resistant (MDR) carbapenemase producing Acinetobacter baumanii in
Indian intensive care units. J Pharm Res 2013;7(2):175-80.
Arora S, Munshi N. Comparative assessment of antibiotic susceptibility
pattern of Gram-negative pathogens isolated from intensive care unit
patients in Pune. Br Microbiol Res J 2015;10(2):1-9.
Chaudhary M, Payasi A. Clinical, microbial efficacy and tolerability
of Elores, a novel antibiotic adjuvant entity in ESBL producing
pathogens: Prospective randomized controlled clinical trial. J Pharm
Res 2013;7(4):275-80.
Jain A. Acute left lung abscess caused by multidrug-resistant
Pseudomonas aeruginosa treated with Elores: A case study. Int J Adv
Res 2015;3(7):173-6.
Chaudhary M, Payasi A. Susceptibility trend of drugs among
metallo β-lactamase producing strains of Escherichia coli, Klebsiella
pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa
in India. Int J Adv Pharm Biol Chem 2015;4(2);303-12.
Chaudhary M, Payasi A. Inhibition of metallo beta-lactamases by
Elores. J Antimicrob Photonics 2013;128:177-82.
Goyal S. Management of pneumonia with multiloculated left pleural
effusion caused by extended spectrum beta-lactamases producing
Klebsiella pneumoniae. Int J Clin Biomed Res 2015;1(4):73-6.
Gupta N. A case study: Viral pneumonia induced acute respiratory
distress syndrome with super infection of ESBL producing Klebsiella
pneumonia treated with antibiotic adjuvant entity: Elores. Int J Adv Res
;3(8):136-9.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.